FOLH1 and prostate carcinoma: Both standard and MRI‐Linac guided MDT in PSMA‐PET detected OPCa can be effective in prolonging biochemical PFS, time to next intervention and PSA progression across a heterogeneous population of varying prostate cancer subtypes.